Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs

Journal Title: Chronic Diseases Journal - Year 2014, Vol 2, Issue 2

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is the most common chronic disease involving joints. Anti-cyclic citrullinated peptide (anti-CCP) as a specific antibody is a reliable index to early diagnosis of RA. Disease-modifying anti-rheumatic drugs (DMARDs) can reduce progression of RA joint destruction. The present study aimed to investigate the effects of DMARDs in reducing serum anti-CCP. METHODS: A cross-sectional study was performed on 30 patients including 22 females and 8 males RA patients according to the American College of Rheumatology (ACR) classification criteria, who referred to the Rheumatology Clinic. Treatment with DMARD group started at the beginning of the study (May 2009). At 1st and 6th month of the study, clinical findings and disease activities were recorded and anti-CCP was measured. RESULTS: At the beginning and the end of the study, morning stiffness for more than 1 h and involvement of three areas were, 28 (93%) and 12 (40%), respectively. Indicators of disease severity in patients, the mean ± SD serum levels of erythrocyte sedimentation rate at the beginning and end, were 40.7 (30-59) mm/1 h and 13.4 (9-86) respectively. Anti-CCP at the beginning and end of the study was 141.83 (65.8-101.09) U/ml and 65.8 (62-92) U/ml respectively (P < 0.05). Disease Activity Score in 28 joints and rheumatoid factor positive and C-reactive protein positive were significantly different at the onset and at the end of the study (P < 0.05). CONCLUSION: Measurement of serum anti-CCP is a helpful index of treatment response and monitoring of treatment efficacy in patients with RA.

Authors and Affiliations

Nasrin Moghimi, Feisal Farshadi, Mahin Lashkari, Ali Delpisheh, Abdorrahim Afkhamzadeh, Namamali Azadi

Keywords

Related Articles

The frequency of skin cancers in Kermanshah City, Iran, during the years 2003-2012

BACKGROUND: Skin cancer is the most common malignancy in the world, and besides the malignant type that has a high mortality rate, other cancers causes many complications and deaths as well. The incidence of skin cancer...

Association of chronic medical conditions with preterm labor

BACKGROUND: Prematurity is the most common cause of neonatal death and according to Millennium Development Goal (MDG), two-thirds of all under-five deaths should be reduced by 2015. Therefore, this study examined factors...

Comparing the therapeutic effects of three herbal medicine (cinnamon, fenugreek, and coriander) on hemoglobin A1C and blood lipids in type II diabetic patients

BACKGROUND: Cinnamon, fenugreek and coriander are among those herbs that are probably effective in lowering glucose; however, different results have been found in observed studies, and the effectiveness of these herbs is...

Chronic inflammatory lesions of the jaws and orofacial tissues

BACKGROUND: Chronic inflammation is a persistent inflammation characterized by tissue repair which may occur around the jaws due to varying causes. This study aims to review its clinico-pathologic features. METHODS: The...

The relationship between the manners of parenting by parents and the extent of anxiety among the students

BACKGROUND: Mental health among the children and adolescents is an essential part of public welfare and health. The transfer of values and culture, and children health are made via training. According to conducted studie...

Download PDF file
  • EP ID EP285010
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Nasrin Moghimi, Feisal Farshadi, Mahin Lashkari, Ali Delpisheh, Abdorrahim Afkhamzadeh, Namamali Azadi (2014). Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs. Chronic Diseases Journal, 2(2), 74-79. https://europub.co.uk/articles/-A-285010